# Current FDA shortages: Cardiovascular

Current ingredient pages containing FDA therapeutic_categories value 'Cardiovascular'.

- [Bumetanide Injection](https://citefacts.com/shortages/bumetanide-injection)
- [Conivaptan Hydrochloride Injection](https://citefacts.com/shortages/conivaptan-hydrochloride-injection)
- [Dobutamine Hydrochloride Injection](https://citefacts.com/shortages/dobutamine-hydrochloride-injection)
- [Dopamine Hydrochloride Injection](https://citefacts.com/shortages/dopamine-hydrochloride-injection)
- [Furosemide Injection](https://citefacts.com/shortages/furosemide-injection)
- [Furosemide Oral Solution](https://citefacts.com/shortages/furosemide-oral-solution)
- [Lidocaine Hydrochloride Injection](https://citefacts.com/shortages/lidocaine-hydrochloride-injection)
- [Propranolol Hydrochloride Injection](https://citefacts.com/shortages/propranolol-hydrochloride-injection)
- [Quinapril Hydrochloride Tablet](https://citefacts.com/shortages/quinapril-hydrochloride-tablet)
- [Quinapril/Hydrochlorothiazide Tablet](https://citefacts.com/shortages/quinapril-hydrochlorothiazide-tablet)
